Table 5.
Top ten most cited references related to non-small cell lung cancer and metabolism.
| Rank | Citations | Title | Author | Journal | Year | DOI |
|---|---|---|---|---|---|---|
| 1 | 190 | Hallmarks of cancer: the next generation | Douglas Hanahan | CELL | 2011 | 10.1016/J.CELL.2011.02.013 |
| 2 | 180 | Cancer Statistics, 2021 | Rebecca L Siegel | CA-CANCER J CLIN | 2021 | 10.3322/CAAC.21654 |
| 3 | 168 | Global cancer statistics | Ahmedin Jemal | CA-CANCER J CLIN | 2011 | 10.3322/CAAC.20107 |
| 4 | 141 | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Matthew G Vander Heiden | SCIENCE | 2009 | 10.1126/SCIENCE.1160809 |
| 5 | 104 | The biology and management of non-small cell lung cancer | Roy S Herbst | NATURE | 2018 | 10.1038/NATURE25183 |
| 6 | 97 | New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) | E A Eisenhauer | EUR J CANCER | 2009 | 10.1016/J.EJCA.2008.10.026 |
| 7 | 96 | From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors | Richard L Wahl | J NUCL MED | 2009 | 10.2967/JNUMED.108.057307 |
| 8 | 91 | Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer | Martin Reck | NEW ENGL J MED | 2016 | 10.1056/NEJMOA1606774 |
| 9 | 88 | Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer | Hossein Borghaei | NEW ENGL J MED | 2015 | 10.1056/NEJMOA1507643 |
| 10 | 81 | On the origin of cancer cells | Otto Warburg | SCIENCE | 1956 | 10.1126/SCIENCE.123.3191.309 |